The G-33A and C-133A mutations downregulate the expression of the TM gene and lower the concentration of the plasma TM protein, which results in carotid atherosclerosis, venous thromboembolic disease, and the onset of acute myocardial infarction [21,22] in smokers. This evidence concerns the gene THBD and venous thromboembolism.